Changes in Clinical Features and Severity of COVID-19 with the Emergence of Omicron Variants: A Shift Towards a Common Disease
Saori Kawamura,Fumihiro Yamaguchi,Rui Kusakado,Yoshihiro Go,Shiho Nohmi,Chinatsu Yoshizaki,Yuki Yoshida,Kensuke Izumizaki,Yuichiro Saito,Hitoshi Kobayashi,Kento Hirata,Kenta Miyo,Chika Kondo,Mamiko Kanzaki,Yize Ding,Takuya Yokoe,Sei Kobayashi,Hiroshi Suzuki
DOI: https://doi.org/10.2147/idr.s492816
2024-12-18
Infection and Drug Resistance
Abstract:Saori Kawamura, 1, &ast Fumihiro Yamaguchi, 1, &ast Rui Kusakado, 1 Yoshihiro Go, 1 Shiho Nohmi, 1 Chinatsu Yoshizaki, 1 Yuki Yoshida, 1 Kensuke Izumizaki, 1 Yuichiro Saito, 1 Hitoshi Kobayashi, 1 Kento Hirata, 1 Kenta Miyo, 1 Chika Kondo, 1 Mamiko Kanzaki, 1 Yize Ding, 1 Takuya Yokoe, 1 Sei Kobayashi, 2 Hiroshi Suzuki 3 1 Department of Respiratory Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan; 2 Department of Otolaryngology, Showa University Fujigaoka Hospital, Yokohama, Japan; 3 Department of Cardiovascular Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan &astThese authors contributed equally to this work Correspondence: Saori Kawamura, Department of Respiratory Medicine, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama, 227-8501, Japan, Tel +81-45-971-1151, Email Background: The emergence of the Omicron variant of severe acute respiratory syndrome coronavirus-2 has significantly altered the clinical features and severity of coronavirus disease 2019 (COVID-19). Objective: This study aims to evaluate whether the clinical factors that previously predicted COVID-19 remain valid following the emergence of the Omicron variant. Methods: This cross-sectional study was conducted at Showa University Fujigaoka Hospital from April 2022 to March 2023. A total of 576 patients with suspected COVID-19 were included, of which 258 (44.8%) were diagnosed with COVID-19 based on real-time reverse-transcription polymerase chain reaction tests. Clinical data were collected retrospectively, and multivariate logistic regression was used to analyze factors associated with a COVID-19 diagnosis. Results: Of the 258 patients diagnosed with COVID-19, 60% had mild disease, and the overall severity was lower than in previous reports prior to the emergence of the Omicron variant. In the multivariate analysis, only C-reactive protein (CRP) levels were significantly associated with COVID-19 (odds ratio, 0.3164; 95% confidence interval, 0.2077– 0.4819), while factors such as age, sex, body mass index, lactate dehydrogenase, and comorbidities were not significantly associated. Non-COVID-19 cases were primarily bacterial infections, accounting for 57.2% of the non-COVID-19 diagnoses. Mortality rates did not differ significantly between the COVID-19 and non-COVID-19 groups. Conclusion: The clinical characteristics of COVID-19 have become less distinct since the emergence of the Omicron variant, with CRP being the primary marker associated with a COVID-19 diagnosis. As COVID-19 continues to transition towards a more common infectious disease, distinguishing it will become increasingly challenging. Keywords: severe acute respiratory syndrome coronavirus-2, coronavirus disease 2019, Omicron variants, C-reactive protein The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) first emerged at the end of 2019, and Omicron variants have been reported worldwide since November 2021, raising concerns about their infectivity, transmissibility, and antigenicity. 1,2 Compared to previous lineages, Omicron variants exhibit increased infection rates and immune escape. 3,4 However, Omicron variants are associated with lower rates of severe disease and mortality compared to earlier lineages. 5,6 Even before the emergence of the Omicron variant, clinically suspected cases of coronavirus disease 2019 (COVID-19) were sometimes missed due to the lack of characteristic symptoms, resulting in large clusters in our hospital. To address this issue, we investigated the efficacy of combining real-time reverse transcription-polymerase chain reaction (rRT-PCR) testing with clinical features to predict COVID-19 in the context of nosocomial infection control. Among 1087 patients admitted to an isolation ward, several factors were identified as significant predictors of COVID-19. This previous study suggests that performing at least two rRT-PCR tests is necessary to reliably exclude COVID-19. These findings highlight the importance of utilizing both clinical factors and repeated rRT-PCR testing to effectively prevent nosocomial transmission of the virus. 7 In this study, we collected medical records after the emergence of Omicron variants in a similar manner. Although several studies have compared the clinical symptoms, imaging findings, and other characteristics of previous lineages and Omicron variants, no studies have compared established methodologies for the definitive diagnosis of COVID-19. Therefore, the aim -Abstract Truncated-
pharmacology & pharmacy,infectious diseases